Skip to main content

Table 1 Baseline demographics for the total cohort and split by smoking status

From: Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study

 

Total n = 3,670

Current smoker n= 2,056

Quitted <1 year n=284

Quitted ≥1 – <5 years n=711

Quitted ≥5years n=619

Age

59.8 (5.4)

58.9 (4.9)

59.8 (5.3)

60.4 (5.5)

62.1 (6.2)

height (cm)

178 (7)

178 (7)

179 (7)

178 (7)

177 (7)

FEV 1 /FVC

72.2 (9.4)

72.8 (9)

72.8 (9.1)

71.8 (10.2)

71.9 (9.4)

FEV 1 [L]

3.4 (0.73)

3.4 (0.8)

3.4 (0.7)

3.5 (0.8)

3.4 (0.7)

FEV 1 [%]

98.5 (18.5)

99.9 (20)

100 (18)

97.1 (19.4)

97.6 (17.9)

Packyears

40.8 (17.9)

40.0 (16.4)

41.0 (17.5)

43.1 (20.2)

40.6 (19.5)

observation time (years)*

3.0 (2.9 – 3.1)

3.0 (2.9-3.1)

3.0 (2.9-3.1)

3.0 (2.9-3.1)

3.0 (2.9-3.1)

GOLD classification

     

normal (%)

65.5

63.2

65.5

68.8

69.1

stage I (%)

22.0

23.4

20.4

20.8

19.2

stage II (%)

10.9

11.6

12.0

9.1

10.3

stage III (%)

1.6

1.8

2.1

1.3

1.5

stage IV (%)

0.1

0.1

0

0

0

Presence of respiratory symptoms

     

cough (%)

32.0

46.0

24.9

14.5

10.7

wheezing (%)

23.8

33.0

20.9

13.1

7.4

dyspnea (%)

29.5

34.4

29.5

23.3

20.8

mucus (%)

30.0

39.6

26.0

17.8

15.2

lung volume <-950 HU (%)*

8.8 (5.1 – 14.1)

6.8 (3.9 – 11.5)

10.5 (6.7 – 15.2)

11.3 (7.4 – 17.2)

11.9 (7.5 – 16.9)

lung volume <-910 HU (%)*

35.2 (24.1 – 46.0)

30.2 (20.1 – 41.9)

38.4 (28.7 – 47.9)

40.9 (30.6 – 50.7)

41.2 (31.6 – 51.4)

perc15 (HU)

−935 (19)

−930 (21)

−939 (16)

−942 (18)

−942 (17)

  1. Mean and standard deviation (SD) is provided*median (Q25 – Q75).